Characterization of the immunomodulatory and anti-Helicobacter pylori properties of the human gastric isolate Lactobacillus rhamnosus UCO-25A

References

• Ansari SA, Devi S, Tenguria S, Kumar A, Ahmed N. 2014. Helicobacter pylori protein HP0986 (TieA) interacts with mouse TNFR1 and triggers proinflammatory and proapoptotic signaling pathways in cultured macrophage cells (RAW 264.7). Cytokine. 68:110–117. doi:10.1016/j.cyto.2014.03.006
   PubMed Web of Science ®Google Scholar
• Atherton JC. 2006. The pathogenesis of Helicobacter pylori induced gastro-duodenal diseases. Annu Rev Pathol Mech Dis. 1:63–96. doi:10.1146/annurev.pathol.1.110304.100125
   PubMed Web of Science ®Google Scholar
• Backert S, Neddermann M, Maubach G, Naumann M. 2016. Pathogenesis of Helicobacter pylori infection. Helicobacter. 21:19–25. doi:10.1111/hel.12335
   PubMedGoogle Scholar
• Bauer B, Meyer TF. 2011. The human gastric pathogen Helicobacter pylori and its association with gastric cancer and ulcer disease. Ulcers. 2011:1–23. doi:10.1155/2011/340157
   Google Scholar
• Brandt S, Kwok T, Hartig R, Konig W, Backert S. 2005. NF- B activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA. 102:9300–9305. doi:10.1073/pnas.0409873102
   PubMed Web of Science ®Google Scholar
• Brawner KM, Kumar R, Serrano CA, Ptacek T, Lefkowitz E, Morrow CD, Zhi D, Kyanam-Kabir-Baig KR, Smythies LE, Harris PR, et al. 2017. Helicobacter pylori infection is associated with an altered gastric microbiota in children. Mucosal Immunol. 10:1169–1177. doi:10.1038/mi.2016.131
   PubMed Web of Science ®Google Scholar
• Chen J, Domingue JC, Sears CL. 2017. Microbiota dysbiosis in select human cancers: evidence of association and causality. Semin Immunol. 32:25–34. doi:10.1016/j.smim.2017.08.001
   PubMed Web of Science ®Google Scholar
• Cizginer S, Ordulu Z, Kadayifci A. 2014. Approach to Helicobacter pylori infection in geriatric population. World J Gastrointest Pharmacol Therapeut. 5:139–147. doi:10.4292/wjgpt.v5.i3.139
   PubMedGoogle Scholar
• Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G, Wu WK, Wong SH, Chen Z, Sung JJY, et al. 2017. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 67:1024–1032.
   PubMed Web of Science ®Google Scholar
• Da Costa DM, Dos Santos Pereira E, Rabenhorst S. 2015. What exists beyond cagA and vacA? Helicobacter pylori genes in gastric diseases. World J Gastroenterol. 21:10563–10572. doi:10.3748/wjg.v21.i37.10563
   PubMed Web of Science ®Google Scholar
• Delgado S, Leite AMO, Ruas-Madiedo P, Mayo B. 2015. Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis. Front Microbiol. 5:1–8.
   Web of Science ®Google Scholar
• Eftang LL, Esbensen Y, Tannaes TM, Bukholm IRK, Bukholm G. 2012. Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol. 12:9. doi:10.1186/1471-2180-12-9
   PubMed Web of Science ®Google Scholar
• Fehlings M, Drobbe L, Moos V, Viveros PR, Hagen J, Beigier-Bompadre M, Pang E, Belogolova E, Churin Y, Schneider T, et al. 2012. Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes. Infect Immun. 80:2724–2734. doi:10.1128/IAI.00381-12
   PubMed Web of Science ®Google Scholar
• Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, and Ferlay J. 2017. International Agency for Research on Cancer. Cancer incidence in five continents. [Internet]. [cited 2018 Feb 5]. http://ci5.iarc.fr.
   Google Scholar
• García A, Sáez K, Delgado C, González CL. 2012. Low co-existence rates of Lactobacillus spp. and Helicobacter pylori detected in gastric biopsies from patients with gastrointestinal symptoms. Rev Esp Enferm Dig. 104:473–478. doi:10.4321/S1130-01082012000900005
   PubMed Web of Science ®Google Scholar
• Garcia CA, Henriquez AP, Retamal RC, Pineda CS, Delgado Sch C, Gonzalez CC. 2009. Probiotic properties of Lactobacillus spp isolated from gastric biopsies of Helicobacter pylori infected and non-infected individuals. Rev Med Chil. 137:369–376.
   PubMed Web of Science ®Google Scholar
• García-Castillo V, Sanhueza E, McNerney E, Onate SA, García A. 2016. Review microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle. J Med Microbiol. 65:1347–1362. doi:10.1099/jmm.0.000371
   PubMed Web of Science ®Google Scholar
• Goderska K, Agudo Pena S, Alarcon T. 2017. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 102:1–7.
   PubMed Web of Science ®Google Scholar
• Herbert RA. 1990. Methods for enumerating microorganisms and determining biomass in natural environments. In: Grigorova R, Norris JR, editors. Methods in microbiology. Vol. 22, Academic Press, Elsevier Ltd. p. 1–39.
   Google Scholar
• Homan M, Orel R. 2015. Are probiotics useful in Helicobacter pylori eradication? World J Gastroenterol. 21:10644–10653. doi:10.3748/wjg.v21.i37.10644
   PubMed Web of Science ®Google Scholar
• Kameoka S, Kameyama T, Hayashi T, Sato S, Ohnishi N, Hayashi T, Murata-Kamiya N, Higashi H, Hatakeyama M, Takaoka A. 2016. Helicobacter pylori induces IL-1β protein through the inflammasome activation in differentiated macrophagic cells. Biomed Res. 37:21–27. doi:10.2220/biomedres.37.21
   PubMed Web of Science ®Google Scholar
• Kaur B, Balgir PP, Kumar B, Garg N. 2010. Helicobacter pylori infection: efficacy of probiotics and role of genome wide association studies. Arch Clin Microbiol. 1–12.
   Google Scholar
• Kinoshita H, Hirata Y, Nakagawa H, Sakamoto K, Hayakawa Y, Takahashi R, Nakata W, Sakitani K, Serizawa T, Hikiba Y, et al. 2013. Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLoS One. 8:e60914. doi:10.1371/journal.pone.0060914
   PubMed Web of Science ®Google Scholar
• Klymiuk I, Bilgilier C, Stadlmann A, Thannesberger J, Kastner MT, Högenauer C, Püspök A, Biowski-Frotz S, Schrutka-Kölbl C, Thallinger GG, et al. 2017. The human gastric microbiome is predicated upon infection with Helicobacter pylori. Front Microbiol. 8:2508. doi:10.3389/fmicb.2017.02508
   PubMed Web of Science ®Google Scholar
• Kumar S, Hanning CR, Rieman DJ, Lee JC, Lotze MT, Brigham-Burke MR, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, et al. 2002. Interleukin-1F7b (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7b binds to the IL-18 receptor but does not induce IFN-γ production. Cytokine. 18:61–71. doi:10.1006/cyto.2002.0873
   PubMed Web of Science ®Google Scholar
• Lebeer S, Verhoeven TLA, Vélez MP, Vanderleyden J, De Keersmaecker S. 2007. Impact of environmental and genetic factors on biofilm formation by the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol. 73:6768–6775. doi:10.1128/AEM.01393-07
   PubMed Web of Science ®Google Scholar
• Leccese Terraf MC, Juárez Tomás MS, Rault L, Le Loir Y, Even S, Nader-Macías M. 2016. Biofilms of vaginal Lactobacillus reuteri CRL 1324 and Lactobacillus rhamnosus CRL 1332: kinetics of formation and matrix characterization. Arch Microbiol. 198:689–700. doi:10.1007/s00203-016-1225-5
   PubMed Web of Science ®Google Scholar
• Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, Potter A, Varro A, Eibach D, Suerbaum S, et al. 2011. Lack of commensal flora in Helicobacter pylori -infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology. 140:210–220. doi:10.1053/j.gastro.2010.09.048
   PubMed Web of Science ®Google Scholar
• Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Leo AD. 2018. Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis. World J Gastroenterol. 24:139–149. doi:10.3748/wjg.v24.i1.139
   PubMed Web of Science ®Google Scholar
• Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y. 2005. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell. 16:4954–4966. doi:10.1091/mbc.e05-05-0426
   PubMed Web of Science ®Google Scholar
• Maldonado C, De Moreno De Leblanc A, Vinderola G, Bibas Bonet ME, Perdigón G. 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol. 14:485–492.
   PubMedGoogle Scholar
• Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ, Brodie EL, Dominguez-Bello MG. 2011. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. isme J. 5:574–579. doi:10.1038/ismej.2010.149
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, et al. 2017. European Helicobacter and microbiota study group and consensus panel. Management of Helicobacter pylori infection the Maastricht V/Florence Consensus Report. Gut. 66:6–30. doi:10.1136/gutjnl-2016-312288
   PubMed Web of Science ®Google Scholar
• Marcus EA, Vagin O, Tokhtaeva E, Sachs G, Scott DR. 2013. Helicobacter pylori impedes acid-induced tightening of gastric epithelial junctions. AJP Gastrointest Liver Physiol. 305:G731–G739. doi:10.1152/ajpgi.00209.2013
   PubMed Web of Science ®Google Scholar
• McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, Rivera-Nieves J. 2011. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA. 108:16711–16716. doi:10.1073/pnas.1111982108
   PubMed Web of Science ®Google Scholar
• Nair MRB, Chouhan D, Gupta S, Sen, Chattopadhyay S. 2016. Fermented foods: are they tasty medicines for Helicobacter pylori associated peptic ulcer and gastric cancer?. Front Microbiol. 7:1148.
   PubMed Web of Science ®Google Scholar
• Naito Y, Yoshikawa T. 2002. Molecular and cellular mechanisms involved in Helicobacter pylori–induced inflammation and oxidative stress. Free Radic Biol Med. 33:323–336. doi:10.1016/S0891-5849(02)00868-7
   PubMed Web of Science ®Google Scholar
• Olson JK, Navarro JB, Allen JM, McCulloh CJ, Mashburn-Warren L, Wang Y, Varaljay VA, Bailey MT, Goodman SD, Besner GE. 2018. An enhanced Lactobacillus reuteri biofilm formulation that increases protection against experimental necrotizing enterocolitis. Am J Physiol Liver Physiol. 315:G408–G419.
   PubMed Web of Science ®Google Scholar
• Olson JK, Rager TM, Navarro JB, Mashburn-Warren L, Goodman SD, Besner GE. 2016. Harvesting the benefits of biofilms: a novel probiotic delivery system for the prevention of necrotizing enterocolitis. J Pediatr Surg. 51:936–941. doi:10.1016/j.jpedsurg.2016.02.062
   PubMed Web of Science ®Google Scholar
• Patel A, Shah N, Prajapati JB. 2014. Clinical application of probiotics in the treatment of Helicobacter pylori infection–a brief review. J Microbiol Immunol Infect. 47:429–437. doi:10.1016/j.jmii.2013.03.010
   PubMedGoogle Scholar
• Peek RM, Fiske C, Wilson KT. 2010. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev. 90:831–858. doi:10.1152/physrev.00039.2009
   PubMed Web of Science ®Google Scholar
• Peña JA, Versalovic J. 2003. Lactobacillus rhamnosus GG decreases TNF-a production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol. 5:277–285. doi:10.1046/j.1462-5822.2003.t01-1-00275.x
   PubMed Web of Science ®Google Scholar
• Posselt G, Backert S, Wessler S. 2013. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal. 11:77. doi:10.1186/1478-811X-11-77
   PubMed Web of Science ®Google Scholar
• Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C. 2004. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut. 53:1082–1089. doi:10.1136/gut.2003.029736
   PubMed Web of Science ®Google Scholar
• Rolig AS, Cech C, Ahler E, Carter JE, Ottemann KM. 2013. The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota. Infect Immun. 81:1382–1389. doi:10.1128/IAI.00044-13
   PubMed Web of Science ®Google Scholar
• Roos S, Engstrand L, Jonsson H. 2005. Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov., and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. Int J Syst Evol Microbiol. 55:77–82. doi:10.1099/ijs.0.63083-0
   PubMed Web of Science ®Google Scholar
• Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. 2001. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother. 47:709–710. doi:10.1093/jac/47.5.709
   PubMed Web of Science ®Google Scholar
• Salas-Jara MJ, Sanhueza EA, Retamal-Díaz A, González C, Urrutia H, García A. 2016. Probiotic Lactobacillus fermentum UCO-979C biofilm formation on AGS and Caco-2 cells and Helicobacter pylori inhibition. Biofouling. 32:1245–1257. doi:10.1080/08927014.2016.1249367
   PubMed Web of Science ®Google Scholar
• Salva S, Villena J, Alvarez S. 2010. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int J Food Microbiol. 141:82–89. doi:10.1016/j.ijfoodmicro.2010.03.013
   PubMed Web of Science ®Google Scholar
• Sato M, Miura K, Kageyama C, Sakae H, Obayashi Y, Kawahara Y, Matsushita O, Yokota K, Okada H. 2019. Association of host immunity with Helicobacter pylori infection in recurrent gastric cancer. Infect Agents Cancer. 14:4. doi:10.1186/s13027-019-0221-1
   PubMed Web of Science ®Google Scholar
• Schwab C, Tveit AT, Schleper C, Urich T. 2014. Gene expression of lactobacilli in murine forestomach biofilms. Microb Biotechnol. 7:347–359. doi:10.1111/1751-7915.12126
   PubMed Web of Science ®Google Scholar
• Sgouras D, Maragkoudakis P, Petraki K, Eriotou E, Michopoulos S, Tsakalidou E, Mentis A. 2004. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol. 70:518–526. doi:10.1128/AEM.70.1.518-526.2004
   PubMed Web of Science ®Google Scholar
• Shah MA. 2015. Update on metastatic gastric and esophageal cancers. J Clin Oncol. 33:1760–1769. doi:10.1200/JCO.2014.60.1799
   PubMed Web of Science ®Google Scholar
• Shan Y, Lu X, Han Y, Li X, Wang X, Shao C, Wang L, Liu Z, Tang W, Sun Y, et al. 2015. Helicobacter pylori outer membrane protein 18 (Hp1125) is involved in persistent colonization by evading interferon-γ signaling. Biomed Res Int. 2015:1. doi:10.1155/2015/571280
   Google Scholar
• Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Ćirković I, Ruzicka F. 2007. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 115:891–899. doi:10.1111/j.1600-0463.2007.apm_630.x
   PubMed Web of Science ®Google Scholar
• Sunanliganon C, Thong-Ngam D, Tumwasorn S, Klaikeaw N. 2012. Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammation. World J Gastroenterol. 18:2472–2480. doi:10.3748/wjg.v18.i20.2472
   PubMed Web of Science ®Google Scholar
• Walker MM, Talley NJ. 2014. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract—beyond the era of Helicobacter pylori. Aliment Pharmacol Ther. 39:767–779. doi:10.1111/apt.12666
   PubMed Web of Science ®Google Scholar
• Wang F, Mao Z, Liu D, Yu J, Wang Y, Ye W, Lin D, Zhou N, Xie Y. 2017. Overexpression of Tim-3 reduces Helicobacter pylori–associated inflammation through TLR4/NFκB signaling in vitro. Mol Med Rep. 15:3252–3258. doi:10.3892/mmr.2017.6346
   PubMed Web of Science ®Google Scholar
• Wang YH, Wu JJ, Lei HY. 2009. When Helicobacter pylori invades and replicates in the cells. Autophagy. 5:540–542. doi:10.4161/auto.5.4.8167
   PubMed Web of Science ®Google Scholar
• White JR, Winter JA, Robinson K. 2015. Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes. J Inflamm Res. 8:137–147.
   PubMed Web of Science ®Google Scholar
• Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, Fukuda R, Kojima S, Nishina M, Sudo H, et al. 2005. Relationship between gastric mucosal IL-8 levels and histological gastritis in patients with Helicobacter pylori infection. Tokai J Exp Clin Med. 30:83–88.
   PubMedGoogle Scholar
• Yamada S, Kato S, Matsuhisa T, Makonkawkeyoon L, Yoshida M, Chakrabandhu T, Lertprasertsuk N, Suttharat P, Chakrabandhu B, Nishiumi S, et al. 2013. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer. World J Gastroenterol. 19:2941–2949. doi:10.3748/wjg.v19.i19.2941
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, Graham DY. 2004. Role of Interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori Infection. Gastroenterology. 126:1030–1043. doi:10.1053/j.gastro.2003.12.048
   PubMed Web of Science ®Google Scholar
• Yao Z, Fenoglio S, Gao DC, Camiolo M, Stiles B, Lindsted T, Schlederer M, Johns C, Altorki N, Mittal V, et al. 2010. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc Natl Acad Sci USA. 107:15535–15540. doi:10.1073/pnas.1009472107
   PubMed Web of Science ®Google Scholar